109 related articles for article (PubMed ID: 25394899)
1. Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma.
Ben Dhiab M; Ziadi S; Ksiaa F; Louhichi T; Ben Gacem R; Ben Zineb A; Amara K; Hachana M; Trimeche M
Tumour Biol; 2015 Mar; 36(3):1963-71. PubMed ID: 25394899
[TBL] [Abstract][Full Text] [Related]
2. Investigation of miR9-1, miR9-2 and miR9-3 Methylation in Hodgkin Lymphoma.
Ben Dhiab M; Ziadi S; Louhichi T; Ben Gacem R; Ksiaa F; Trimeche M
Pathobiology; 2015; 82(5):195-202. PubMed ID: 26337487
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of microRNA expression in Hodgkin lymphoma.
Navarro A; Díaz T; Cordeiro A; Beyá MD; Ferrer G; Fuster D; Martinez A; Monzó M
Leuk Lymphoma; 2015; 56(9):2683-9. PubMed ID: 25586608
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas.
Dhiab MB; Ziadi S; Mestiri S; Gacem RB; Ksiaa F; Trimeche M
Cell Oncol (Dordr); 2015 Dec; 38(6):453-62. PubMed ID: 26350502
[TBL] [Abstract][Full Text] [Related]
5. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
6. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
Cerci JJ; Pracchia LF; Linardi CC; Pitella FA; Delbeke D; Izaki M; Trindade E; Soares J; Buccheri V; Meneghetti JC
J Nucl Med; 2010 Sep; 51(9):1337-43. PubMed ID: 20720036
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
10. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Nourse JP; Keane C; Bhatnagar A; Gandhi MK
Clin Cancer Res; 2014 Jan; 20(1):253-64. PubMed ID: 24222179
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
[TBL] [Abstract][Full Text] [Related]
14. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma.
Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J
Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognostic factors of 62 cases with Hodgkin lymphoma].
Wan WL; Tian L; Wang J; Zhang W; Jing HM; Wang JJ; Liu Y; Hou SL; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):618-21. PubMed ID: 23906458
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
18. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma.
Song A; Ye J; Zhang K; Yu H; Gao Y; Wang H; Sun L; Xing X; Yang K; Zhao M
Leuk Res; 2015 May; 39(5):536-43. PubMed ID: 25798877
[TBL] [Abstract][Full Text] [Related]
20. Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas.
Karihtala P; Porvari K; Soini Y; Haapasaari KM
Oxid Med Cell Longev; 2017; 2017():2696071. PubMed ID: 28377796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
